S. Boriani et al., CHORDOMA OF THE SPINE ABOVE THE SACRUM - TREATMENT AND OUTCOME IN 21 CASES, Spine (Philadelphia, Pa. 1976), 21(13), 1996, pp. 1569-1577
Study Design. Twenty-one cases of chordoma arising in the mobile spine
were retrospectively reviewed. Objectives. All the cases were submitt
ed to oncologic and surgical staging to correlate treatment and outcom
e. Summary of Background Data. Excluding plasmacytomas, chordoma is th
e most frequent primary malignant tumor of the spine, occurring mainly
in elderly men. The course of the disease is slow, metastases occur l
ate, and death can result from complications related to local extensio
n of the disease. Complete excision of the tumor according to oncologi
c criteria can be hampered by extension of the tumor and by anatomic c
onstraints in the mobile spine. Methods. All charts, radiographs, and
images were reviewed. The composite information provided by this revie
w allowed for oncologic and surgical staging of these cases. Treatment
was defined according to Ennekings criteria. All the patients were fo
llowed for determination of their status clinically and radiographical
ly Results. Ten patients died (1 to 137 months after treatment, mean 6
5 months); four patients are alive with the disease; only seven patien
ts (33%) are symptom free at the final follow-up (39 to 112 months aft
er treatment, mean 65 months). Conventional radiation therapy was not
effective in eradicating the tumor, even if associated with palliative
or debulking surgery: of 15 cases, 12 were associated with recurrence
of progression. Intralesional surgery also was not effective (two rec
urrences in two cases, 18 to 41 months later). En bloc excision of the
lesion, sometimes combined with radiation therapy as an adjuvant, obt
ained the best results (four patients disease free at 39 to 112 months
, mean 77 months). Conclusions. En bloc excision-even if marginal-is t
he treatment of choice of chordomas of the spine. Early diagnosis and
careful surgical staging and planning are necessary. Megavoltage radia
tion can be administered as an adjuvant.